12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

• Unicycive Therapeutics UNCY shares rose 27.9% to $1.65 during Thursday's after-market session. The company's market cap stands at $24.7 million.
• Clearside Biomedical CLSD stock increased by 15.06% to $1.68. The company's market cap stands at $100.2 million.
• Cingulate CING shares increased by 12.49% to $1.35. The company's market cap stands at $15.2 million.
• Aerie Pharmaceuticals AERI stock moved upwards by 8.47% to $6.4. The company's market cap stands at $303.0 million. As per the news, the Q4 earnings report came out today.
• Silk Road Medical SILK stock rose 7.69% to $34.0. The company's market cap stands at $1.1 billion. As per the news, the Q4 earnings report came out today.
• Avalon Globocare AVCO stock moved upwards by 5.83% to $0.78. The market value of their outstanding shares is at $68.9 million.

Losers

• Pulmatrix PULM stock fell 15.7% to $0.32 during Thursday's after-market session. Pulmatrix's trading volume hit 423.4K shares by close, accounting for 40.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $17.7 million.
• Dermata Therapeutics DRMA shares decreased by 11.67% to $1.06. The market value of their outstanding shares is at $8.8 million.
• Virpax Pharmaceuticals VRPX stock fell 11.22% to $1.82. The market value of their outstanding shares is at $21.3 million.
• OPKO Health OPK shares declined by 8.98% to $2.94. At the close, OPKO Health's trading volume reached 104.9K shares. This is 1.9% of its average volume over the last 100 days. The company's market cap stands at $2.0 billion. As per the news, the Q4 earnings report came out today.
• Tabula Rasa HealthCare TRHC stock decreased by 7.71% to $4.31. The company's market cap stands at $110.8 million. As per the news, the Q4 earnings report came out today.
• Histogen HSTO stock declined by 6.43% to $0.22. The market value of their outstanding shares is at $10.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.